Priority Reports

The impact of the written request process on drug development in childhood cancer

  1. Kristen M. Snyder MD1,
  2. Gregory Reaman MD1,*,
  3. Debbie Avant PhD2,
  4. Richard Pazdur MD1

Article first published online: 17 JAN 2013

DOI: 10.1002/pbc.24346

Issue

Pediatric Blood & Cancer

Pediatric Blood & Cancer

Volume 60, Issue 4, pages 531–537, April 2013

Additional Information

How to Cite

Snyder, K. M., Reaman, G., Avant, D. and Pazdur, R. (2013), The impact of the written request process on drug development in childhood cancer. Pediatr. Blood Cancer, 60: 531–537. doi: 10.1002/pbc.24346

Author Information

  1. 1

    Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, Silver Spring, Maryland

  2. 2

    Office of Pediatric Therapeutics, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, Maryland

*Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 22, Room 2202, Silver Spring, MD 20901-0002.

Publication History

  1. Issue published online: 13 FEB 2013
  2. Article first published online: 17 JAN 2013
  3. Manuscript Accepted: 30 AUG 2012
  4. Manuscript Received: 10 APR 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (110K)

No citations currently available for this article.

View Full Article (HTML) Get PDF (110K)